Exclusive: J&amp;J is in talks with the government of Japan, @gatesfoundation about locking up allocations of its potential #COVID19 vaccine as it prepares to kick off human trials, CFO Joseph Wolk told @CarlODonnell26 @Manasmishra24 in an interview. $JNJ

 https://t.co/YJJt5uEBzW